Pesquisas alternativas:
disease levels » disease level (Expandir a Pesquisa), dismutase levels (Expandir a Pesquisa), decrease levels (Expandir a Pesquisa)
developed teen » developed test (Expandir a Pesquisa), developed open (Expandir a Pesquisa), developed between (Expandir a Pesquisa)
fds developed » foods developed (Expandir a Pesquisa), has developed (Expandir a Pesquisa), films developed (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level race (Expandir a Pesquisa)
drug disease » during disease (Expandir a Pesquisa), drug release (Expandir a Pesquisa)
doses level » dose level (Expandir a Pesquisa), does level (Expandir a Pesquisa), dose levels (Expandir a Pesquisa)
levels over » levels after (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
drugs fds » drugs fda (Expandir a Pesquisa), drugs ads (Expandir a Pesquisa), drugs foods (Expandir a Pesquisa)
disease levels » disease level (Expandir a Pesquisa), dismutase levels (Expandir a Pesquisa), decrease levels (Expandir a Pesquisa)
developed teen » developed test (Expandir a Pesquisa), developed open (Expandir a Pesquisa), developed between (Expandir a Pesquisa)
fds developed » foods developed (Expandir a Pesquisa), has developed (Expandir a Pesquisa), films developed (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level race (Expandir a Pesquisa)
drug disease » during disease (Expandir a Pesquisa), drug release (Expandir a Pesquisa)
doses level » dose level (Expandir a Pesquisa), does level (Expandir a Pesquisa), dose levels (Expandir a Pesquisa)
levels over » levels after (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
drugs fds » drugs fda (Expandir a Pesquisa), drugs ads (Expandir a Pesquisa), drugs foods (Expandir a Pesquisa)
1
Por Daniel Domingo-Fernández, Yojana Gadiya, Abhishek Patel, Sarah Mubeen, Daniel Rivas-Barragan, Chris W Diana, Biswapriya B Misra, David Healey, Joe Rokicki, Viswa Colluru
Publicado em 2022-02-01
“.... Here, we present RPath, a novel algorithm that prioritizes drugs for a given disease by reasoning over...”Publicado em 2022-02-01
Obter o texto integral
Artigo
2
Por van den Berg, Charlotte H. S. B., Smit, Colette, Bakker, Margreet, Geskus, Ronald B., Berkhout, Ben, Jurriaans, Suzanne, Coutinho, Roel A., Wolthers, Katja C., Prins, Maria
Publicado em 2007
Assuntos:
“...Infectious Diseases...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Doubova (Dubova), Svetlana Vladislavovna, Reyes-Morales, Hortensia, Torres-Arreola, Laura del Pilar, Suárez-Ortega, Magdalena
Publicado em 2007
“... conclusive results. In the present study, we determined the frequency of potential drug-drug and drug-disease...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Joshi, Shailendra, Ellis, Jason A., Emala, Charles W.
Publicado no J Neuroanaesth Crit Care (2014)
“...For over six decades intra-arterial (IA) drugs have been sporadically used for the treatment...”Publicado no J Neuroanaesth Crit Care (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
6
Por Kondo, Yuki, Ishitsuka, Yoichi, Kawabata, Nobuhiro, Iwamoto, Nobuhide, Takahashi, Risa, Narita, Yuki, Kadowaki, Daisuke, Hirata, Sumio, Uchino, Satoru, Irie, Tetsumi
Publicado no PLoS One (2019)
“... professionals to avoid using unsuitable over-the-counter (OTC) drugs. Recently, qualified, registered...”Publicado no PLoS One (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“... and explores the role of drug levels and immunogenicity (antibody formation) on the efficacy of anti-TNFα...”
Obter o texto integral
Obter o texto integral
Artigo
8
“... and explores the role of drug levels and immunogenicity (antibody formation) on the efficacy of anti-TNFα...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Hendrikx, Jeroen J.M.A., Haanen, John B.A.G., Voest, Emile E., Schellens, Jan H.M., Huitema, Alwin D.R., Beijnen, Jos H.
Publicado no Oncologist (2017)
Assuntos:
“...New Drug Development and Clinical Pharmacology...”Publicado no Oncologist (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Publicado em 2008
“... for these, use of lipid-lowering drugs became relatively less common over time. The incidence of myocardial...”Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“... could be based on an "all or none" detection of the marker rather than on drug levels....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“... and golimumab, have been proven to be effective for the treatment of patients with Crohn's disease...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
14
Por Yadav, Bhagwan, Wennerberg, Krister, Aittokallio, Tero, Tang, Jing
Publicado no Comput Struct Biotechnol J (2015)
“... positive rate at a low level. Further, rather than relying on a single parameter to assess drug interaction...”Publicado no Comput Struct Biotechnol J (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Srivastava, Prashant K., van Eyll, Jonathan, Godard, Patrice, Mazzuferi, Manuela, Delahaye-Duriez, Andree, Van Steenwinckel, Juliette, Gressens, Pierre, Danis, Benedicte, Vandenplas, Catherine, Foerch, Patrik, Leclercq, Karine, Mairet-Coello, Georges, Cardenas, Alvaro, Vanclef, Frederic, Laaniste, Liisi, Niespodziany, Isabelle, Keaney, James, Gasser, Julien, Gillet, Gaelle, Shkura, Kirill, Chong, Seon-Ah, Behmoaras, Jacques, Kadiu, Irena, Petretto, Enrico, Kaminski, Rafal M., Johnson, Michael R.
Publicado no Nat Commun (2018)
“...The identification of drug targets is highly challenging, particularly for diseases of the brain...”Publicado no Nat Commun (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Gulzira Zhussupova, Galina Skvirskaya, Vladimir Reshetnikov, Viktorija Dragojevic-Simic, Nemanja Rancic, Dinara Utepova, Mihajlo Jakovljevic
Publicado em 2020-02-01
Assuntos:
“...inpatient level...”Publicado em 2020-02-01
Obter o texto integral
Artigo
17
Por Li, Yan, Tellez, Armando, Rousselle, Serge D., Dillon, Krista N., Garza, Javier A., Barry, Chris, Granada, Juan F.
Publicado no Catheter Cardiovasc Interv (2015)
Assuntos:
“...Coronary Artery Disease...”Publicado no Catheter Cardiovasc Interv (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Schulman, Ira G.
Publicado em 2010
“... that control development, differentiation, and homeostasis. Over the last 15 years a growing number of nuclear...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Wages, Phillip A., Kim, Hye-Young H., Korade, Zeljka, Porter, Ned A.
Publicado no J Lipid Res (2018)
“... to modulate 7-DHC or Des levels in a neural cell line. Over 20% of the collection was shown to impact Chol...”Publicado no J Lipid Res (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... disease-modifying anti-rheumatic drug (DMARD) combination therapy. METHODS: Forty patients with early RA...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo